Aggressive pituitary tumors and pituitary carcinomas: from pathology to treatment
P Burman, O Casar-Borota… - The Journal of …, 2023 - academic.oup.com
Aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs) are heterogeneous with
regard to clinical presentation, proliferative markers, clinical course, and response to …
regard to clinical presentation, proliferative markers, clinical course, and response to …
[HTML][HTML] Organoid models of the pituitary gland in health and disease
E Laporte, H Vankelecom - Frontiers in Endocrinology, 2023 - frontiersin.org
The pituitary gland represents the hub of our endocrine system. Its cells produce specific
hormones that direct multiple vital physiological processes such as body growth, fertility, and …
hormones that direct multiple vital physiological processes such as body growth, fertility, and …
[HTML][HTML] Aggressive pituitary tumors (PitNETs)
H Nishioka - Endocrine journal, 2023 - jstage.jst.go.jp
The majority of anterior pituitary tumors behave benignly, that is, they grow slowly and do not
metastasize, and were therefore called adenomas. However, they would frequently invade …
metastasize, and were therefore called adenomas. However, they would frequently invade …
Refractory somatotroph adenomas
MR Gadelha, L Kasuki - Pituitary, 2023 - Springer
Somatotroph adenomas are usually controlled with standard therapy, which can include
surgery, medical treatment and radiotherapy. Some tumors have a more aggressive …
surgery, medical treatment and radiotherapy. Some tumors have a more aggressive …
[HTML][HTML] Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors
E Whyte, M Nezu, C Chik… - Endocrinology and …, 2023 - synapse.koreamed.org
Pituitary neuroendocrine tumors (PitNETs) are the third most frequently diagnosed
intracranial tumors, with nonfunctioning PitNETs (nfPitNETs) accounting for 30% of all …
intracranial tumors, with nonfunctioning PitNETs (nfPitNETs) accounting for 30% of all …
[HTML][HTML] Multidisciplinary management of difficult/aggressive growth-hormone pituitary neuro-endocrine tumors
A Bianchi, S Chiloiro, A Giampietro… - Frontiers in …, 2023 - frontiersin.org
Growth Hormone-secreting adenomas exhibits variable biological behavior and
heterogeneous natural history, ranging from small adenomas and mild disease, to invasive …
heterogeneous natural history, ranging from small adenomas and mild disease, to invasive …
[PDF][PDF] Perez-Ri as
P Burman, O Casar-Borota - LG, & Dekkers, OM, 2023 - scholarlypublications …
Aggressive pituitary tumors (APTs) and pituitary carcinomas (PCs) are heterogeneous with
regard to clinical presentation, proliferative markers, clinical course, and response to …
regard to clinical presentation, proliferative markers, clinical course, and response to …
[HTML][HTML] Contemporary Management of Acromegaly: A Practical Approach
MH Almalki, MM Ahmad, A Alqahtani… - Journal of Diabetes …, 2022 - thieme-connect.com
Acromegaly is a rare, chronic disease that is, in more than 95% of cases, caused by a
growth hormone (GH)-secreting pituitary adenoma. Overproduction of insulin-like growth …
growth hormone (GH)-secreting pituitary adenoma. Overproduction of insulin-like growth …
Machine learning to comprehensively reveal signature genes and regulatory mechanisms in pituitary tumors
Q Wang, R Xiao, Y Xia - 2023 - researchsquare.com
Background Pituitary tumors are among the rare tumors of the central nervous system. With
advances in screening, the incidence of pituitary tumors is increasing every year. The …
advances in screening, the incidence of pituitary tumors is increasing every year. The …
CAPTEM 療法を施行した難治性プロラクチノーマ及び難治性先端巨大症の検討
石田敦士, 福岡秀規, 志智大城, 井下尚子… - 日本内分泌学会 …, 2023 - jstage.jst.go.jp
* 1 森山記念病院 間脳下垂体センター,* 2 同 病理診断科* 3 神戸大学医学部附属病院
糖尿病・内分泌内科* 4 神戸大学大学院医学研究科 糖尿病・内分泌内科学まえがき 2017 年 …
糖尿病・内分泌内科* 4 神戸大学大学院医学研究科 糖尿病・内分泌内科学まえがき 2017 年 …